
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
iCardiac Technologies was acquired by ERT in December, 2017. ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that our customers can move ahead with confidence. With nearly 50 years of clinical and therapeutic experience, we balance knowledge of what works with a vision for whats next, so we can adapt without compromising standards. Powered by the companys EXPERT technology platform, our solutions enhance trial oversight, enable site optimization, increase patient engagement, and measure the efficacy of new clinical treatments while ensuring patient safety. Over the past four years, more than half...
Cardiac safety services,respiratory services,phase i qt assessment,tqt studies,phase ii-iv cardiac safety,spirometry,consulting,electronic clinical outcome assessments (ecoa),centralized trial oversight,and advanced imaging
Icardiac operates in the Biotechnology research industry.
Icardiac's revenue is 11m - 100m
Icardiac has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.